Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva makes $82 per share offer for rival Mylan
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
14. Teva Pharmaceutical Industries | FiercePharma
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Faces Rocky Path to Recovery After Debt | Fortune
Teva Stock Skids As First-Quarter Sales Decline — Again | Investor's Business Daily